Literature DB >> 28836863

The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox.

Gregory D Koblentz.   

Abstract

In March 2017, the American biotech company Tonix announced that a Canadian scientist had synthesized horsepox virus as part of a project to develop a safer vaccine against smallpox. The first de novo synthesis of an orthopoxvirus, a closely related group of viruses that includes horsepox and the variola virus that causes smallpox, crosses an important Rubicon in the field of biosecurity. The synthesis of horsepox virus takes the world one step closer to the reemergence of smallpox as a threat to global health security. That threat has been held at bay for the past 40 years by the extreme difficulty of obtaining variola virus and the availability of effective medical countermeasures. The techniques demonstrated by the synthesis of horsepox have the potential to erase both of these barriers. The primary risk posed by this research is that it will open the door to the routine and widespread synthesis of other orthopoxviruses, such as vaccinia, for use in research, public health, and medicine. The normalization and globalization of orthopoxvirus synthesis for these beneficial applications will create a cadre of laboratories and scientists that will also have the capability and expertise to create infectious variola virus from synthetic DNA. Unless the safeguards against the synthesis of variola virus are strengthened, the capability to reintroduce smallpox into the human population will be globally distributed and either loosely or completely unregulated, providing the foundation for a disgruntled or radicalized scientist, sophisticated terrorist group, unscrupulous company, or rogue state to recreate one of humanity's most feared microbial enemies. The reemergence of smallpox-because of a laboratory accident or an intentional release-would be a global health disaster. International organizations, national governments, the DNA synthesis industry, and the synthetic biology community all have a role to play in devising new approaches to preventing the reemergence of smallpox.

Entities:  

Keywords:  Biosecurity; Dual-use research; Oversight; Smallpox; Synthetic biology

Mesh:

Year:  2017        PMID: 28836863     DOI: 10.1089/hs.2017.0061

Source DB:  PubMed          Journal:  Health Secur        ISSN: 2326-5094


  19 in total

1.  Synthetic genome engineering gets infectious.

Authors:  Leslie A Mitchell; Tom Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

2.  A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.

Authors:  Eric M Mucker; Joseph W Golden; Christopher D Hammerbeck; Jennifer M Kishimori; Michael Royals; Mathew D Joselyn; John Ballantyne; Aysegul Nalca; Jay W Hooper
Journal:  J Virol       Date:  2021-12-01       Impact factor: 6.549

3.  Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination.

Authors:  Lei Yang; Lingqian Tian; Leshan Li; Qiuhong Liu; Xiang Guo; Yuan Zhou; Rongjuan Pei; Xinwen Chen; Yun Wang
Journal:  Virol Sin       Date:  2022-02-28       Impact factor: 6.947

4.  A Critical Analysis of the Scientific and Commercial Rationales for the De Novo Synthesis of Horsepox Virus.

Authors:  Gregory D Koblentz
Journal:  mSphere       Date:  2018-03-07       Impact factor: 4.389

5.  Bayesian Phylogeography and Pathogenic Characterization of Smallpox Based on HA, ATI, and CrmB Genes.

Authors:  Dillon C Adam; Matthew Scotch; Chandini Raina MacIntyre
Journal:  Mol Biol Evol       Date:  2018-11-01       Impact factor: 16.240

6.  Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.

Authors:  Eric M Mucker; Suzanne E Wollen-Roberts; Adrienne Kimmel; Josh Shamblin; Darryl Sampey; Jay W Hooper
Journal:  PLoS Negl Trop Dis       Date:  2018-06-21

7.  Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence.

Authors:  C Raina MacIntyre; Valentina Costantino; Xin Chen; Eva Segelov; Abrar Ahmad Chughtai; Anthony Kelleher; Mohana Kunasekaran; John Michael Lane
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883

8.  Application of a Risk Analysis Tool to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Outbreak in Saudi Arabia.

Authors:  Xin Chen; Abrar A Chughtai; Chandini R MacIntyre
Journal:  Risk Anal       Date:  2020-03-13       Impact factor: 4.302

9.  Synthetic horsepox viruses and the continuing debate about dual use research.

Authors:  Ryan S Noyce; David H Evans
Journal:  PLoS Pathog       Date:  2018-10-04       Impact factor: 6.823

10.  Synthetic viruses-Anything new?

Authors:  Volker Thiel
Journal:  PLoS Pathog       Date:  2018-10-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.